| JYHB1801155 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2018-09-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-11-15 | view |
| JXHL1700068 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-04-10 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-10-12 | view |
| JYHB1500411 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-04-10 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-05-31 | view |
| JXHB2000022 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-09-04 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-03 | view |
| JXSL1800064 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXHL1700140 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2017-07-31 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-12-20 | view |
| JXHL1500295 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs | Import Drug Application | 2015-12-11 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-08-12 | view |
| JXSB2000054 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2021-05-09 | view |
| JXHL1900314 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-18 | AbbVie Inc. | Abbvie Inc | In Review | 2019-11-16 | view |
| JXHL1800005 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-01-15 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-06-07 | view |
| JXHL1600128 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2016-11-07 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-05-22 | view |
| JXHL1400106 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
| JXHS2000004 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc;Abbvie Ireland Nl BV | Certificate Issued | 2020-12-08 | view |
| JXSL1800063 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-08 | view |
| JXHL1700079 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-04-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-10-12 | view |
| JYHB1501395 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-09-28 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-25 | view |
| JXHL2000263 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
| JXHL1900276 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-10-29 | AbbVie Inc. | Abbvie Inc | In Review | 2019-10-25 | view |
| JXSL1700057 | Rovalpituzumab Tesirine | rovalpituzumab tesirine | Other | Biological Products | Import Drug Application | 2017-09-27 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-07-05 | view |
| JXHL1600048 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs | Import Drug Application | 2016-04-13 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-12-20 | view |
